Hironori Fujii

7PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Clinical pharmacy and pharmacy practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 29, 2026
Effectiveness of continuous pharmacist intervention at maintaining dose intensity in postoperative adjuvant S-1 chemotherapy for gastric cancer: a multicentre retrospective study.

|Dec 19, 2024
Pharmacist intervention and identification of adverse events related to treatment efficacy in cancer chemotherapy to improve clinical outcomes.

Hironori Fujii

|Jul 10, 2024
CONUT score as a predictor for anamorelin efficacy in patients with cancer cachexia receiving chemotherapy.

Hironori Fujii, Akitaka Makiyama, Kayoko Nishimura

|Jun 26, 2023
Effectiveness of countermeasure for polypharmacy by multidisciplinary team review in patients with diabetes mellitus.

Shohei Nishida, Takehiro Kato, Yuichi Hayashi

|Mar 13, 2020
Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study.

Hironori Fujii, Nobuhisa Matsuhashi, Mika Kitahora

|Jun 05, 2019
High total bilirubin level is a significant risk factor for severe neutropenia in patients receiving irinotecan-based chemotherapy.

Yunami Yamada, Hironori Fujii, Koichi Ohata

Pageof 2

Frequent Collaborators

1 joint publications

Shohei Nishida

1 joint publications

Takehiro Kato

1 joint publications

Yuichi Hayashi

1 joint publications

Hirotoshi Iihara